The use of enterosorption with polysorbates in symptomatic therapy of patients with ovarian cancer
Temchenko, O.I.
Klinichna Khirurhiia 5: 50
1998
ISSN/ISBN: 0023-2130 PMID: 9787586 Document Number: 486513
Document emailed within 1 workday
Related Documents
Neĭmark, A.I. 1990: The use of enterosorption in the combined therapy of patients with urolithiasis complicated by chronic kidney failure Terapevticheskii Arkhiv 62(6): 81-83Ivanov, S.; Batashki, I. 2008: Five years survival in patients with endometrioid ovarian cancer versus patients with serous ovarian cancer Akusherstvo i Ginekologiia 47(5): 9-11
Kawai, S.; Nishida, Y.; Nakada, M.; Tachikawa, M.; Miyagoshi, E. 1985: Standards of nursing of patients with ovarian and uterine cancer--through the nursing actions toward patients with cervical and ovarian cancer scheduled for total hysterectomy Nursing Technique 31(8): 1017-1024
Akhmedova, S.A.; Sergeeva, N.S.; Marshutina, N.V.; Mishunina, M.P.; Novikova, E.G. 2003: Tumor-associated antigen CA-125 in patients with ovarian cancer receiving various combinations of therapy Voprosy Onkologii 49(1): 95-98
Suzuki, M.; Sekiguchi, I.; Tamada, T.; Sakurabayashi, I.; Kawai, T. 1985: Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors Rinsho Byori. Japanese Journal of Clinical Pathology 33(2): 173-177
Rose, D.P.; Davis, T.E. 1980: Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients Cancer Research 40(11): 4043-4047
Fukuyama, A.; Yokoyama, Y.; Wada, J.; Hashimoto, T.; Oda, T.; Sato, S.; Mizunuma, H. 2009: Two cases of ovarian cancer at an early stage incidentally detected using transvaginal ultrasonography in screening: importance of interval for ovarian cancer screening and selection of population with a high risk of ovarian cancer European Journal of Gynaecological Oncology 30(2): 208-210
Hernádi, Z.; Juhász, B.; Póka, R.; Mahunka, I.; Lampé, L. 1987: Analysis of the effectiveness and adverse effects of the drug combinations CAP and CEP in the therapy of patients in the advanced stages of ovarian cancer Orvosi Hetilap 128(47): 2457-2461
Hartge, P.; Hayes, R.; Reding, D.; Sherman, M.E.; Prorok, P.; Schiffman, M.; Buys, S. 2000: Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial American Journal of Obstetrics and Gynecology 183(5): 1232-1237
Zhyl'chuk, V.I.; Alistratov, O.V.; Vorontsova, A.L. 1998: The evaluation of the efficacy of adjuvant laferon therapy in the combined treatment of patients with ovarian cancer based on the monitoring of the tumor marker Ca-125 in the blood serum Likars'ka Sprava 2: 137-139
Bobkova, L.P.; Beĭko, V.A.; Grishilo, P.V.; Shevchuk, A.V.; Glinskiĭ, V.V.; Mikhalovskiĭ, S.V.; Strelko, V.V.; Berezhnaia, N.M. 1990: Enterosorption in the treatment of patients with chronic urticaria Vrachebnoe Delo 7: 87-90
Li, L.; Ji, J.; Wang, J.-B.; Niyazi, M.; Qiao, Y.-L.; Boffetta, P. 2012: Attributable causes of breast cancer and ovarian cancer in china: reproductive factors, oral contraceptives and hormone replacement therapy Chinese Journal of Cancer Research 24(1): 9-17
Ishikawa, M.; Nakayama, K.; Rahman, M.T.; Rahman, M.; Katagiri, H.; Katagiri, A.; Ishibashi, T.; Iida, K.; Nakayama, N.; Miyazaki, K. 2014: Therapy-related myelodysplastic syndrome and acute myeloid leukemia following chemotherapy (paclitaxel and carboplatin) and radiation therapy in ovarian cancer: a case report European Journal of Gynaecological Oncology 35(4): 443-448
Penault-Llorca, F.; Levrel, O.; Clémenson, A.; Kwiatkowski, F.; Pomel, C.; Fouilhoux, G.; De Latour, M.; Curé, H.; Déchelotte, P.; Fonck, Y.; Dauplat, J. 2000: Assessment of different histoprognosis grading systems for primary ovarian cancer: 100 patients given the same treatment for primary ovarian adenocarcinoma Journal de Gynecologie Obstetrique et Biologie de la Reproduction 29(6): 548-554
Zlatnik, E.I.; Golotina, L.I. 2005: The use of roncoleukin for LAK therapy in ovarian cancer Voprosy Onkologii 51(6): 680-684
Pickel, J.H. 1983: New aspects in the therapy of ovarian cancer Fortschritte der Medizin 101(30): 1387-1389
Markman, M. 2008: Second-line therapy for ovarian cancer Clinical Advances in Hematology and Oncology: H&o 6(6): 421-422
Chovanec, J.; Feranec, R.; Náležinská, M.; Cacek, T. 2017: Surgical therapy of ovarian cancer Rozhledy v chirurgii: mesicnik Ceskoslovenske chirurgicke spolecnosti 96(6): 237-241
Coukos, G.; Rubin, S.C. 2001: Gene therapy for ovarian cancer Oncology 15(9): 1197-1204; 1207; Discussion: 1207-1208
Sabbatini, P.; Spriggs, D. 1998: Salvage therapy for ovarian cancer Oncology 12(6): 833